Gene · 3316
Papers3,243
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,243
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-541-3p enhances the radiosensitivity of prostate cancer cells by inhibiting HSP27 expression and downregulating β-catenin. | Cell Death Discov | 2021 | 33462201 | PubTator, text mining | PubMed |
| Prepubertal exposure to high dose of cadmium induces hypothalamic injury through transcriptome profiling alteration and neuronal degeneration in female rats. | Chem Biol Interact | 2021 | 33453195 | PubTator, text mining | PubMed |
| Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms. | Int J Mol Sci | 2021 | 33440869 | PubTator, text mining | PubMed |
| Different responses of apoptotic, inflammatory and heat shock protein gene expression to a single bout of high-intensity interval exercise between physically active and inactive men. | Appl Physiol Nutr Metab | 2021 | 33439763 | PubTator, text mining | PubMed |
| Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders. | Int J Environ Res Public Health | 2021 | 33435142 | PubTator, text mining | PubMed |
| O-GlcNAcylated peptides and proteins for structural and functional studies. | Curr Opin Struct Biol | 2021 | 33434850 | PubTator, text mining | PubMed |
| Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future. | J Immunother Cancer | 2021 | 33431631 | PubTator, text mining | PubMed |
| Heat Shock Protein 27 Injection Leads to Caspase Activation in the Visual Pathway and Retinal T-Cell Response. | Int J Mol Sci | 2021 | 33419223 | PubTator, text mining | PubMed |
| The Role of Cellular Prion Protein in Promoting Stemness and Differentiation in Cancer. | Cancers (Basel) | 2021 | 33418999 | PubTator, text mining | PubMed |
| Cancer and Stress: Does It Make a Difference to the Patient When These Two Challenges Collide? | Cancers (Basel) | 2021 | 33418900 | PubTator, text mining | PubMed |
| Cardiotoxic effects of angiogenesis inhibitors. | Clin Sci (Lond) | 2021 | 33404052 | PubTator, text mining | PubMed |
| Analyses of putative anti-cancer potential of three STAT3 signaling inhibitory compounds derived from Salvia officinalis. | Biochem Biophys Rep | 2021 | 33392396 | PubTator, text mining | PubMed |
| Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer. | Theranostics | 2021 | 33391515 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| The role of androgen and its related signals in PCOS. | J Cell Mol Med | 2021 | 33369146 | PubTator, text mining | PubMed |
| Mog1 to tbx5-cryab/hspb2: A novel signalling network potentiates heart failure? | Acta Physiol (Oxf) | 2021 | 33280261 | PubTator, text mining | PubMed |
| Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer. | Cancer Prev Res (Phila) | 2021 | 33115780 | PubTator, text mining | PubMed |
| Optimum health and inhibition of cancer progression by microbiome and resveratrol. | Front Biosci (Landmark Ed) | 2021 | 33049680 | PubTator, text mining | PubMed |
| Differential profiling of prostate tumors versus benign prostatic tissues by using a 2DE-MALDI-TOF-based proteomic approach. | Neoplasma | 2021 | 32977723 | PubTator, text mining | PubMed |
| Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis. | J Mol Cell Biol | 2021 | 32976566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3316/papers?page=46